Company: NOEMW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004368
Chunk: 314

Company: CO2 Energy Transition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 314
---
 of who serves as officers of the Company as
well as whether any changes are made in the Board of Directors. As a potential investor in the Company, you should keep in mind that even
if you own shares of our common stock and wish to vote them at annual or special stockholder meetings, your shares will have little effect
on the outcome of corporate decisions. Because CO2 Energy Transition, LLC will significantly influence the vote on all stockholder matters,
investors may find it difficult to replace our management if they disagree with the way our business is being operated. The interests
of CO2 Energy Transition, LLC may not coincide with our interests or the interests of other stockholders.

CO2 Energy Transition, LLC
acquired its shares of common stock for substantially less than the price of the shares of common stock acquired in our IPO, and/or the
current trading price of our common stock, and may have interests, with respect to their common stock, that are different from other investors
and the concentration of voting power held by CO2 Energy Transition, LLC may have an adverse effect on the price of our common stock.

In addition, as a result of
their substantial ownership in our company, CO2 Energy Transition, LLC may exert a substantial influence on other actions requiring a
stockholder vote, potentially in a manner that you do not support, including amendments to our amended and restated certificate of incorporation
and approval of major corporate transactions. If CO2 Energy Transition, LLC purchases any shares of our common stock in the aftermarket
or in privately negotiated transactions, this would increase its influence over these actions. Accordingly, CO2 Energy Transition, LLC
will exert significant influence over actions requiring a stockholder vote at least until the completion of our initial business combination.

We may amend the terms of the warrants in
a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then outstanding public
warrants.

Our warrants were issued in
registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant
agreement provides that (a) the terms of the warrants may be amended without the consent of any holder for the purpose of (i) curing
any ambiguity or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of
the warrants and the warrant agreement set forth in the prospectus associated with our IPO, or defective provision or (ii) adding